Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c

NF-κB–driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance

(2016) Ching-Feng Chiu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type

(2015) Jiayu Li et al.   Oncotarget

MicroRNA-21 as a potential colon and rectal cancer biomarker

(2014) Tao Li   WORLD JOURNAL OF GASTROENTEROLOGY

Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer

(2012) Naoko Kuzumaki et al.   PLoS One

Change in MicroRNAs Associated with Neuronal Adaptive Responses in the Nucleus Accumbens under Neuropathic Pain

(2011) S. Imai et al.   JOURNAL OF NEUROSCIENCE

Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients

(2011) Monique M. Nijkamp et al.   RADIOTHERAPY AND ONCOLOGY

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands

(2009) H. Takeshima et al.   GENOME RESEARCH

The current status of targeted therapy for non-small cell lung cancer

(2009) H. Francis et al.   INTERNAL MEDICINE JOURNAL

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

(2009) David Jackman et al.   JOURNAL OF CLINICAL ONCOLOGY